Allogeneic non-myeloablative stem cell transplantation for the patients with heavily pre-treated refractory lymphoma. 2001

J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016879 Salvage Therapy A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases. Salvage Treatment,Therapy, Salvage,Salvage Therapies,Salvage Treatments,Therapies, Salvage,Treatment, Salvage,Treatments, Salvage
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
March 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
December 2000, Bone marrow transplantation,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
May 2009, Seminars in oncology nursing,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
February 2004, Zhongguo shi yan xue ye xue za zhi,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
September 2010, European review for medical and pharmacological sciences,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
September 2003, The Israel Medical Association journal : IMAJ,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
November 2000, Haematologica,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
April 2004, Hong Kong medical journal = Xianggang yi xue za zhi,
J H Lee, and J H Lee, and Y K Kang, and J S Lee, and W K Kim, and K H Lee
January 2003, Urologic oncology,
Copied contents to your clipboard!